The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
One-year impact of a large-scale pilot multimodal personalized early cancer detection and prevention program for individuals at high risk of cancers.
 
Tarek Ben Ahmed
No Relationships to Disclose
 
Maryam Karimi
No Relationships to Disclose
 
Pamela Abdayem
No Relationships to Disclose
 
Lucie Veron
No Relationships to Disclose
 
Thomas Pudlarz
No Relationships to Disclose
 
Marion Aupomerol
No Relationships to Disclose
 
Helene Caron
No Relationships to Disclose
 
Bruno Raynard
No Relationships to Disclose
 
Ines Luis
Honoraria - AstraZeneca (Inst); Chugai Pharma (Inst); Institut de recherches internationales Servier (Inst); Novartis (Inst); Sandoz; Servier Monde (Inst)
Research Funding - Resilience Care (Inst)
Travel, Accommodations, Expenses - Novartis; Novartis
 
Claire Bladier
No Relationships to Disclose
 
Sandrine Boucher
No Relationships to Disclose
 
Andre Tardieu
No Relationships to Disclose
 
Eric Douriez
No Relationships to Disclose
 
Jacques-Claude Cittée
No Relationships to Disclose
 
Olivier Caron
Consulting or Advisory Role - Janssen; Syantra
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca (Inst); Besins Healthcare (Inst); ELSAN (Inst); Gilead Sciences (Inst); Rappta Therapeutics (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis (Inst); Pfizer